10 Best Performing Biotech ETFs in 2024 - Insider Monkey
In this article, we discuss the 10 best performing biotech ETFs in 2024.
Source: insidermonkey.com
📰 Tema Cardiovascular News
Tema Cardiovascular News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Tema Cardiovascular. Real-time updates on events, politics, business and more.
Viking stock doubled Tuesday. Here's where the next moves in the obesity space could come from
Anti-obesity drugmakers Novo Nordisk and Eli Lilly have a huge lead on their competition, but it's coming.
Source: cnbc.com
Roche, Pfizer Race To Find Next Ozempic As Pharma Giants Hustle To Join Obesity Treatment Market - Tema Cardiovascular and Metabolic ETF (NASDAQ:HRTS), Altimmune (NASDAQ:ALT)
Weight-loss drugs such as Ozempic and Mounjaro are the leading blockbusters for a new epidemic
Eli Lilly Novo Nordisk World Health Organization Carmot Therapeutics Tale Of Two Investigational Obesity Drugs Altimmune Stock Jumps
Source: benzinga.com
A new ETF dedicated to anti-obesity drugs (Ozempic, Mounjaro, Wegovy)!
A niche issuer launches a biotech ETF whose core holdings include companies benefiting from the GLP-1 weight-loss drug craze. The Tema Cardiovascular and Metabolic ETF tracks companies involved in...
Source: marketscreener.com
Baystreet.ca - Don't Know Which Weight-Loss Stock Will Be the Biggest Winner? Invest in This ETF Instead
There’s a lot of excitement in the weight-loss industry these days. Between Ozempic, Wegovy, Mounjaro, and now Zepbound, investors have been hearing a lot of different names in the industry of late. And there are still more treatments that will ...
Source: baystreet.ca
Wegovy, Ozempic Makers Targeted With New ETF
Tema’s HRTS exposes investors to popular obesity drugs.
Source: yahoo.com
A new ETF will allow investors to cash in on the Ozempic-fueled weight loss craze that's swept markets this year
The Tema Cardiovascular and Metabolic ETF holds positions in around 20 companies, including Novo Nordisk and Eli Lilly.
Eli Lilly Novo Nordisk Tema Cardiovascular Wegovy Maker Novo Nordisk Shares Biotechnology Bloomberg Intelligence
Source: yahoo.com
RBC strategist's top 10 market thoughts for 2024. Plus, why this is no time to be selling Brookfield Infrastructure
A roundup of investment ideas for active investors
Source: theglobeandmail.com
New ETF invested in Ozempic maker and exposed to other obesity drugs falls in first day of trade
The new Tema Cardiovascular and Metabolic ETF fell in its first day of trade. It is exposed to weight-loss drugs including Ozempic.
Source: marketwatch.com
A New Ozempic-Inspired ETF Is Hitting the Stock Market
The Tema Cardiovascular and Metabolic ETF holds positions in around 20 companies, including Novo Nordisk and Eli Lilly.
Eli Lilly Terms Of Service Novo Nordisk Tema Cardiovascular Wegovy Maker Novo Nordisk Shares Biotechnology
Source: businessinsider.com